FDA approves new Type 2 diabetes treatment
from Pharmacy Times
The FDA recently approved Boehringer Ingelheim and Lilly's empagliflozin and linagliptin as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes who can be treated with both of the drug's active ingredients individually.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063